159 related articles for article (PubMed ID: 14678586)
1. Ethnic variation of the P53 codon 72 polymorphism, HPV persistence, and cervical cancer risk.
Inserra P; Abrahamsen M; Papenfuss M; Giuliano AR
Int J STD AIDS; 2003 Dec; 14(12):800-4. PubMed ID: 14678586
[TBL] [Abstract][Full Text] [Related]
2. TP53 polymorphism, HPV infection, and risk of cervical cancer.
Klug SJ; Wilmotte R; Santos C; Almonte M; Herrero R; Guerrero I; Caceres E; Peixoto-Guimaraes D; Lenoir G; Hainaut P; Walboomers JM; Muñoz N
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):1009-12. PubMed ID: 11535556
[TBL] [Abstract][Full Text] [Related]
3. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women.
Bhattacharya P; Sengupta S
Gynecol Oncol; 2005 Oct; 99(1):176-82. PubMed ID: 16054204
[TBL] [Abstract][Full Text] [Related]
4. p53 at codon 72 polymorphism, human papillomavirus infection and cervical lesions: a cross-sectional study from northeastern Italy.
Comar M; Molin GD; Guaschino S; Campello C
Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):210-4. PubMed ID: 15140517
[TBL] [Abstract][Full Text] [Related]
5. [Correlation between P53 codon 72 polymorphism and tumorigenesis of cervical cancer].
Li CY; Liu JH; Huang BJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1396-9. PubMed ID: 15566643
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus infection and P53 codon 72 genotypes in a Hispanic population at high-risk for cervical cancer.
Haws AL; Woeber S; Gomez M; Garza N; Gomez Y; Rady P; He Q; Zhang L; Grady JJ; McCormick JB; Fisher-Hoch SP; Tyring SK
J Med Virol; 2005 Oct; 77(2):265-72. PubMed ID: 16121365
[TBL] [Abstract][Full Text] [Related]
7. No relationship observed between human p53 codon-72 genotype and HPV-associated cervical cancer in a population group with a low arginine-72 allele frequency.
Govan VA; Loubser S; Saleh D; Hoffman M; Williamson AL
Int J Immunogenet; 2007 Jun; 34(3):213-7. PubMed ID: 17504512
[TBL] [Abstract][Full Text] [Related]
8. p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China.
Li T; Lu ZM; Guo M; Wu QJ; Chen KN; Xing HP; Mei Q; Ke Y
Cancer; 2002 Dec; 95(12):2571-6. PubMed ID: 12467072
[TBL] [Abstract][Full Text] [Related]
9. P53 codon 72 polymorphism as a risk factor in the development of HPV-associated cervical cancer.
Dokianakis DN; Spandidos DA
Mol Cell Biol Res Commun; 2000 Feb; 3(2):111-4. PubMed ID: 10775508
[TBL] [Abstract][Full Text] [Related]
10. [Risk factors for cervico-uterine cancer associated to HPV: p53 codon 72 polymorphism in women attending hospital care].
Sifuentes Alvarez A; Reyes Romero M
Ginecol Obstet Mex; 2003 Jan; 71():12-5. PubMed ID: 12708345
[TBL] [Abstract][Full Text] [Related]
11. [Polymorphism in codon 72 of the p53 gene and cervico-uterine cancer risk in Mexico].
Suárez-Rincón AE; Morán-Moguel MC; Montoya-Fuentes H; Gallegos-Arreola MP; Sánchez-Corona J
Ginecol Obstet Mex; 2002 Jul; 70():344-8. PubMed ID: 12221910
[TBL] [Abstract][Full Text] [Related]
12. Integration status of virus DNA and p53 codon 72 polymorphism in human papillomavirus type 16 positive cervical cancers.
Szarka K; Veress G; Juhász A; Kónya J; Sápy T; Soós G; Hernádi Z; Gergely L
Anticancer Res; 2000; 20(3B):2161-7. PubMed ID: 10928171
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of GSTM1, p21, p53 and HPV infection with cervical cancer in Korean women.
Lee SA; Kim JW; Roh JW; Choi JY; Lee KM; Yoo KY; Song YS; Kang D
Gynecol Oncol; 2004 Apr; 93(1):14-8. PubMed ID: 15047208
[TBL] [Abstract][Full Text] [Related]
14. No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection.
Minaguchi T; Kanamori Y; Matsushima M; Yoshikawa H; Taketani Y; Nakamura Y
Cancer Res; 1998 Oct; 58(20):4585-6. PubMed ID: 9788606
[TBL] [Abstract][Full Text] [Related]
15. The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer.
Madeleine MM; Shera K; Schwartz SM; Daling JR; Galloway DA; Wipf GC; Carter JJ; McKnight B; McDougall JK
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):225-7. PubMed ID: 10698487
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus and p53 polymorphism in Lithuanian cervical cancer patients.
Gudleviciene Z; Didziapetriene J; Ramael M; Uleckiene S; Valuckas KP
Gynecol Oncol; 2006 Sep; 102(3):530-3. PubMed ID: 16488468
[TBL] [Abstract][Full Text] [Related]
17. p53 Codon 72 polymorphism, loss of heterozygosity and high-risk human papillomavirus infection in a low-incidence German esophageal squamous cell carcinoma patient cohort.
Pantelis A; Pantelis D; Ruemmele P; Hartmann A; Hofstaedter F; Buettner R; Bootz F; Stoehr R
Oncol Rep; 2007 May; 17(5):1243-8. PubMed ID: 17390072
[TBL] [Abstract][Full Text] [Related]
18. p53 codon 72 polymorphism and HPV status in lung cancer.
Buyru N; Altinisik J; Isin M; Dalay N
Med Sci Monit; 2008 Sep; 14(9):CR493-7. PubMed ID: 18758421
[TBL] [Abstract][Full Text] [Related]
19. CASP8 promoter polymorphism is associated with high-risk HPV types and abnormal cytology but not with cervical cancer.
Chatterjee K; Williamson AL; Hoffman M; Dandara C
J Med Virol; 2011 Apr; 83(4):630-6. PubMed ID: 21328377
[TBL] [Abstract][Full Text] [Related]
20. Detection of oncogenic viruses SV40, BKV, JCV, HCMV, HPV and p53 codon 72 polymorphism in lung carcinoma.
Giuliani L; Jaxmar T; Casadio C; Gariglio M; Manna A; D'Antonio D; Syrjanen K; Favalli C; Ciotti M
Lung Cancer; 2007 Sep; 57(3):273-81. PubMed ID: 17400331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
